WHAT YOU NEED TO KNOW
Why get vaccinated?
•Dengue is one of the leading causes of illness in the Philippines. Worldwide.•Philippines rank 7th among countries and territories with the highest average number of Dengue cases reported to the World Health Organization (WHO) and 4th overall for the Asia Pacific region from 2004 to 2010.
Why get vaccinated?
DENGUE•Is a diseased caused by a dengue virus transmitted by an infected female Aedes mosquito•Signs and symptoms: Fever (>2 days), skin flushing, bleeding of nose or gums, loss of appetite, nausea, vomiting
DENGVAXIA (DENGUE VACCINE)What is DENGUE VACCINE?•Used to help protect a child against dengue caused by
dengue virus serotype 1,2,3, and 4. • It works by stimulating your body’s natural defenses
(immune system) which produces its own protection (antibodies) against the virus that causes dengue disease.
DENGVAXIA (DENGUE VACCINE)• Live, attenuated vaccine & contains 4 dengue virus serotypes-1,2,3, and 4• Preparation : 5-dose per vial (multi-dose), suspension for SQ injection • NO vaccine vial monitor (VVM) label • Indicated for use to children and adults from 9 years to 45 years old• Tetravalent vaccine
DENGVAXIA (DENGUE VACCINE)How many times should an individual get vaccinated?• Given every 6 months. • For Example if one gets the first dose in April, the person will receive
his second dose 6 months after, which is October. The third dose will be given 6 months after the second dose which is April of the following year.
DOSES MONTHS1st dose 02nd dose 63rd dose 12
DENGVAXIA (DENGUE VACCINE)Is the Vaccine effective to prevent dengue disease?
• Yes. Based on the clinical studies conducted in 10 countries across Southeast Asia and Latin America, the vaccine has been shown to be effective in:• Preventing severe dengueby 93.2%• Preventing hospitalized form of dengue by 80.8%• Preventing dengue due to any serotype by 65.6%.
• As with the vaccines, the dengue vaccine may not protect 100% the person who have been vaccinated.
• Dengue vaccination is not a substitute for the protection against mosquito bites and vaccinees are still encouraged to take appropriate precautions to prevent mosquito bites.
• Student beneficiaries will receive the vaccine during a school based immunization program in all public schools scheduled on April 2016 for free.
DENGVAXIA (DENGUE VACCINE)Does it cost anything (payment)?•DOH and DepEd is implementing the dengue
vaccination program for Grade 4 students aged 9 years old and above, enrolled in the School Year 2015-2016.•Student beneficiaries will receive the FREE vaccine
during a school based immunization program in all public elementary schools scheduled on April 2016 for FREE.
DENGVAXIA (DENGUE VACCINE)Where can we get the vaccine?•Vaccine will be available for grade 4 students 9 years
old and above, enrolled in the School Year 2015-2016 at the time of the vaccination in all public elementary schools during a school based immunization program scheduled in April. • Those who will not be eligible for this vaccination
program may ask their physician on how they can get vaccinated against dengue.
DENGVAXIA (DENGUE VACCINE)Who should receive the vaccine?•All 9 years old male and female students enrolled in Grade 4 public schools (SY 2015-2016) shall be vaccinated with 3 doses of the Dengue tetravalent vaccine following the recommended immunization schedule interval.•Only students with signed notification and consent letter shall be vaccinated. •In case of dengue vaccination refusal or the student received only one or two doses of dengue vaccines, he/she shall not be suspended, grounded or reprimanded.
DENGVAXIA (DENGUE VACCINE)Will it be distributed nationwide? If not, how did you consider the priority places?•Dengue vaccination program of the DOH will only be
available in the regions in the Philippines with the highest number of dengue cases annually namely Region III, NCR, and Region IV-A from April 2016-2017. •Nevertheless, the vaccine will be available nationwide
in the private sector. Please ask your physicians on how to access the vaccines.
Who should not receive the vaccine(pregnant, allergies and other diseases)?The vaccine should NOT be given to the following:Children less than 9 years old and adults older than 45Individuals who have known allergies to active substances in the vaccineIndividuals weakened immune system due to genetic defect, HIV infection, or therapies that affect the immune system such as high dose-corticosteroids or chemotherapy.Pregnant or breastfeeding mothers;Individuals suffering from a disease with mild to high fever or acute disease(the vaccine can be given once the individual has recovered)
DENGVAXIA (DENGUE VACCINE)
If someone had already dengue, can they still avail the vaccine?•Yes. Dengue disease is caused by 4 serotypes. Natural infection caused by one of the 4 serotypes confers lifelong immunity from that only serotype but not from the other serotypes. Dengue vaccination can still provide protection against dengue disease. •The vaccine has to be administered at least 3-6 months from the acute episode of dengue. Like all medicines, the dengue vaccine can cause side effects but it is manageable.
DENGVAXIA (DENGUE VACCINE)
What are the possible side effects from being vaccinated? What are the cures for these?Like all medicines, the dengue vaccine can cause side effects but it is manageable.Serious Allergic Reactions:If any of these symptoms occur after leaving the place where your child received the injection, you must consult a doctor IMMEDIATELY:•Difficulty of Breathing•Blueness of tongue or lips•Low blood pressure causing dizziness or collapse•Swelling of the face or throat•A rashWhen these signs or symptoms occur they usually develop quickly after the injection is given while the vaccinee (individual) is still in the vaccination area. Serious allergic reactions are very rare, (may affect up to 1 in 10,000 people) after receiving any vaccine.
DENGVAXIA (DENGUE VACCINE)
Other side effects:The following side effects were reported during the clinical studies in children, adolescents and adults. Most of the reported side effects occurred within 3 days after injection of the vaccine.
Very Common (May affect more than 1 user in 10)•Headache•Generally feeling unwell•Injection site pain•Muscle pain•Fever•Feeling of weakness
Common (May affect up to 1 user in 100)•Injection site: reactions redness, bruising, swelling, and itching
Uncommon•Infections of the upper respiratory tract•Dizziness•Cough•Nausea•Sore Throat•Runny nose
If the vaccinee experience any side effects after vaccination, they are advised to seek immediate medical attention
DENGVAXIA (DENGUE VACCINE)
GENERAL GUIDELINES• DOH shall provide the necessary vaccines and other immunization logistics
(e.g. N/S, safety collector boxes, immunization cards, recording and reporting forms) following the routine system of the distribution of the immunization logistics.• Department of Education (DepEd) shall determine the most appropriate
timing of the immunization sessions, inform teachers/parents/students of the vaccination, provide additional human resource for vaccination, and ensure each eligible student vaccinated and appropriately refer missed students for vaccination. • The Local Government Units (LGUs) health personnel (MDs. Nurses,
midwives, volunteers) shall lead the vaccination in collaboration with schools, hospitals and other partners within the catchment areas.
VACCINATION STRATEGY• What is the vaccination strategy?• School-based, classroom per classroom• Rolling–phase
• When? • Starting April 2016 up to June 2017• April – offer protection to the target population before the PEAK SEASON
• Number of vaccination rounds?• 3 Rounds • Round 1 (Dose 1) : Year 2016 -April, May, June• Round 2 (Dose 2) : Year 2016 - October, November, December • Round 3 (Dose 3) : Year 2017 - April, May, June
Specific Guidelines: Target Eligible Students
ALL 9 years old and above students enrolled in Grade 4 public schools (SY 2015-2016) with consent in Regions NCR,III and IVA (except
participating students in clinical study from San Pablo City, Laguna.
Grade 4 student aged less than 9 years old : DO NOT GIVE DENGUE VACCINE
Specific Guidelines: Target Eligible Students
• All vaccinators shall conduct a quick health assessment of every eligible students before vaccination. ASK if the student had/has : ACTIONS REQUIRED, if present
Fever If any is present, DEFER
vaccination until child is well.
Refer for medical management.Set a definite date for the
vaccination.
Cough Rashes Headache Received any vaccine for the last 1
month Enrolled in Dengue clinical study
from San Pablo City, LagunaDO NOT GIVE the dengue
vaccine. Recipient of blood products for the
last 3 months With history of allergy to previous
dose Taking corticosteroids or
chemotherapy Pregnant or Breastfeeding
Specific Guidelines: Schedule of Administration of Dengue
Vaccines • All eligible students shall be vaccinated with the dengue vaccine,
0.5ml, subcutaneous, (SC) at the LEFT deltoid arm following the recommended vaccination schedule:
First Dose : At time of visit with the healthworker, at 9 or 10 years old
Second Dose : At least 6 months after the 1st doseThird Dose : At least 6 months after the 2nd dose
NOTE: Health workers must ensure that those who received the dengue vaccine first dose shall be given the 2nd dose after 6 months and the 3rd dose 6 months after the 2nd dose
Specific Guidelines: Follow-up of Deferred Eligible
Students • Teacher-in-charge shall follow-up the deferred students
but willing to be vaccinated and refer to the catchment health facility.• Students who will be referred and vaccinated at the health
facility shall be accompanied by the school nurse and shall be included in the accomplishment report as vaccinated.
Specific Guidelines: Before Vaccination…
• Clinic/school nurses/teachers shall list all the enrolled students in Grade 4 using the Recording Form 1 (Masterlist of Grade 4 ).
• All clinic/Grade 4 teachers/school nurses shall issue a notification letter indicating the following:• 3 doses of Dengue • Schedule of Vaccination
• All clinic/Grade 4 teachers/school nurses shall ensure the retrieval of the signed notification and consent form.
Specific Guidelines: Adverse Event Following Immunization
(AEFI)• Fear of injections resulting to fainting has been commonly observed in school immunization. Thus it is recommended that the vaccination sites are situated in areas not conspicuous to the students. Immunization session shall be conducted after recess to ensure that these eligible students have taken their snacks/food to rule-out fainting secondary to hypoglycemia.
• Adverse Events after the receipt of the vaccines, even if it is not clear that the vaccine caused the adverse events should be reported following the existing DOH Issuance Administrative Order No. 2010-0017, “ Guidelines in Surveillance and Response to Adverse Events Following Immunization (AEFI).
• However, a linelist of the minor reactions shall be recorded and submitted to gather information on the various AEFI rates for the Philippines setting.
Specific Guidelines: After Vaccination…
• All vaccinators shall provide all the students with key messages on…• Expected reactions after vaccination •Where to report in case of any vaccine reaction • Issue an immunization card• Indicate the specific dates of next doses
Mild and Temporary ReactionsFAINTING
• Due to fear of injection, or sight of blood, or having not eaten prior to immunization.
• May last for a minute or less.• Keep the child lying down with her feet slightly elevated.• If the symptoms persist, it may require immediate
attention. Bring the child to the nearest health facilities.
SWELLING• Apply alternately cold and warm compress every 15
minutes using clean cloth until swelling disappears in the injection site.
• Do not massage the injection site.
RECORDING AND
REPORTING FORMS
Recording Form1: MasterlistingRegion: _______________________________ Name of School: _____________________________________________________________________________ Section: _______________________________________
Province/City: _________________________ Division: _______________________
Municipality: __________________________ Date:__________________________
Y N Y N 1st dose 2nd dose Age 3rd dose Age Y N
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Note;
Every child ask the following:
1. Cough 5. Recipient of the blood products
2. Fever 6. Taking corticosteroids/ chemotherapy
3. Rashes 7. Pregnant/ breastfeeding
4. Headache 8. Resident of San Pablo City, Laguna/ Cebu City
Grade 4 Students (9 years old)
Parents' ConsentRemarks
Screened*
To be filled up by the Vaccination Team
DeferredDate Vaccinated with Dengue Tetravalent
Recording Form 1 MASTER LISTING FORM for School-based Dengue Vaccination
To be filled up by the School Nurse/ Class Adviser
No.Name
(Surname, First Name, MI) Complete Address Dare of
Birth MM/DD/YY
Age Sex
Name and Signature of RecorderName and Signature of School Nurse/Class Advisor
____________________________________________________________________ ________________________________________________
Name and Signature of Vaccinator
________________________________________________
Reporting Form1: Daily Reporting Form
Region: _______________________________ Name of School: ___________________________________________ Section: _______________________________________
Province/City: _________________________ Division: _______________________
Municipality: __________________________ Date:__________________________
1st dose of Dengue vaccine
%2nd dose of
Dengue vaccine
%3rd dose of
Dengue vaccine
%1st dose of
Dengue vaccine
%
2nd dose of Dengue vaccine
%
3rd dose of
Dengue vaccine
%Sick (cough,
fever, rashes, headache)
Recipient of the blood
products
Taking corticosteroids/ chemotherapy
Pregnant/ breastfeeding
Resident of San Pablo City, Laguna/ Cebu
City, Cebu
No Consent
TOTAL
Prepared by: Name: Noted by: Name:Position: Position:
Reasons for deferral
Reporting Form1
Daily Reporting Form for School-based Dengue Vaccination Grade 4 Students (9 years old)
Total no. of eligible students
Total no. of students vaccinated Total no. of deferred
____________________________________________________________________
__________________________________________________________________________ __________________________________________________________________________
_____________________________________________________________
Reporting Form2: Daily Consolidation FormReporting Form2
Region: _______________________________ Name of School: ________________________________________________ Total no. of eligible:______________
Province/City: _________________________ Division: _______________________
Municipality: __________________________ Date:__________________________
1st dose of Dengue vaccine
%2nd dose of
Dengue vaccine
%3rd dose of
Dengue vaccine
%1st dose of
Dengue vaccine
%
2nd dose of Dengue vaccine
%
3rd dose of
Dengue vaccine
%1st dose of
Dengue vaccine
2nd dose of Dengue vaccine
3rd dose of Dengue vaccine
TOTAL
Prepared by: Name: Noted by: Name:Position: Position:
No. of AEFI
Daily Consolidation Form for School-based Dengue Vaccination Grade 4 Students (9 years old)
Name of Section
Total no. of students vaccinated Total no. of deferred
____________________________________________________________________
__________________________________________________________________________ __________________________________________________________________________
______________________________________________________
Reporting Form3: Weekly Consolidation Form(Please tick reporting level) Region:__________________Province/ City:___________________________Municipality:_____________________ Barangay:___________________________ Date: __________________
1st dose of Dengue vaccine
%2nd dose of
Dengue vaccine
%3rd dose of
Dengue vaccine
%1st dose of
Dengue vaccine
%2nd dose of
Dengue vaccine
%3rd dose of
Dengue vaccine
%1st dose of
Dengue vaccine
%2nd dose of
Dengue vaccine
%3rd dose of
Dengue vaccine
%
Total
Prepared by: Name: Noted by: Name:Position: Position:
Reporting Form3
Grade 4 Students (9 years old)
Total no. of schools
Name of Municipalities and Cities/
Facilities (RHU/BHS)
Total no. of students enrolled
Total no. of students vaccinated
Remarks
Total no. of AEFITotal no. of deferred
Weekly Consolidation Report Form for School-based Dengue Vaccination
____________________________________________________________________
__________________________________________________________________________ ________________________________________________________________
_____________________________________
Flow of Reporting/Deadline School
RHU
Province/City
Regional DOH
National DOH
Preimplementation •Notification/Consent•Masterlist
Implementation•Weekly accomplishment•Final accomplishment per round•AEFI
Flow of Reporting/Deadline (Notification/Consent and Masterlist)
School (March 9, 2016) –School Nurse
RHU/Municipality (March 11, 2016) - EPI Coordinator
Province/City (March 16, 2016) – EPI Coordinator
Regional DOH (March 22, 2016) – EPI/Dengue Coordinator
National DOH (March 26, 2016)
Flow of Reporting/Deadline of Accomplishment starting April 1
School (everyday before 12pm) –Vaccination Team
RHU/Municipality (everyday before 2pm) - EPI Coordinator
Province/City (everyday before 4pm) – EPI Coordinator
Regional DOH (everyday before 5pm) – EPI/Dengue Coordinator
National DOH
THANK YOU
Top Related